A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)
A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)
Recruiting · NCT07564154 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA) | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 1 | 2026-08-11 | NCT07564154 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kali Therapeutics, Inc. | 2 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kali Therapeutics Trial Site | Auckland | New Zealand | 1 |
| Kali Therapeutics Trial Site | Bayswater | Australia | 1 |